ELTX Long Call Strategy

ELTX (Elicio Therapeutics, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.

Elicio Therapeutics, Inc., a clinical-stage biotechnology company, engages in developing a pipeline of novel immunotherapies for the treatment of cancer and other diseases. The company's lead product candidate is ELI-002, an AMP therapeutic vaccine for the treatment of KRAS-driven cancers. It is also developing ELI-004, an AMP-modified CpG adjuvant, a component of ELI-002; ELI-007, a lymph node targeted AMP-peptide vaccine for mutant BRAF-driven cancers; ELI-008, a multivalent lymph node targeted AMP-peptide vaccine for mutant TP53-expressing cancers; ELI-005, a vaccine candidate for the prevention of COVID-19; ELI-011 for the treatment of hematological cancers; and ELI-012, a mKRAS TCR T cell AMP-lifier designs to use in combination with mKRAS-targeted TCR T cell therapy against mKRAS-driven cancers. The company is headquartered in Boston, Massachusetts.

ELTX (Elicio Therapeutics, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $215.7M, a beta of 1.12 versus the broader market, a 52-week range of 5.15-14.93, average daily share volume of 135K, a public-listing history dating back to 2021, approximately 32 full-time employees. These structural characteristics shape how ELTX stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 1.12 places ELTX roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline.

What is a long call on ELTX?

A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration.

Current ELTX snapshot

As of May 15, 2026, spot at $10.68, ATM IV 158.30%, IV rank 28.52%, expected move 45.38%. The long call on ELTX below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.

Why this long call structure on ELTX specifically: ELTX IV at 158.30% is on the cheap side of its 1-year range, which favors premium-buying structures like a ELTX long call, with a market-implied 1-standard-deviation move of approximately 45.38% (roughly $4.85 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated ELTX expiries trade a higher absolute premium for lower per-day decay. Position sizing on ELTX should anchor to the underlying notional of $10.68 per share and to the trader's directional view on ELTX stock.

ELTX long call setup

The ELTX long call below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With ELTX near $10.68, the first option leg uses a $10.68 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed ELTX chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 ELTX shares for the stock leg in covered calls and collars).

ActionTypeStrike / BasisPremium (est)
Buy 1Call$10.68N/A

ELTX long call risk and reward

Net Premium / Debit
N/A
Max Profit (per contract)
Unbounded
Max Loss (per contract)
Unbounded
Breakeven(s)
None on modeled curve
Risk / Reward Ratio
N/A

Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium.

ELTX long call payoff curve

Modeled P&L at expiration across a range of underlying prices for the long call on ELTX. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

When traders use long call on ELTX

Long calls on ELTX express a bullish thesis with defined risk; traders use them ahead of ELTX catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.

ELTX thesis for this long call

The market-implied 1-standard-deviation range for ELTX extends from approximately $5.83 on the downside to $15.53 on the upside. A ELTX long call expresses a directional view that the underlying closes above the strike plus premium at expiration, ideally with implied volatility holding or expanding to preserve extrinsic value through the hold period. Current ELTX IV rank near 28.52% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on ELTX at 158.30%. As a Healthcare name, ELTX options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to ELTX-specific events.

ELTX long call positions are structurally bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. ELTX positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move ELTX alongside the broader basket even when ELTX-specific fundamentals are unchanged. Long-premium structures like a long call on ELTX are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current ELTX chain quotes before placing a trade.

Frequently asked questions

What is a long call on ELTX?
A long call on ELTX is the long call strategy applied to ELTX (stock). The strategy is structurally bullish: A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration. With ELTX stock trading near $10.68, the strikes shown on this page are snapped to the nearest listed ELTX chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
How are ELTX long call max profit and max loss calculated?
Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium. For the ELTX long call priced from the end-of-day chain at a 30-day expiry (ATM IV 158.30%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a ELTX long call?
The breakeven for the ELTX long call priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current ELTX market-implied 1-standard-deviation expected move is approximately 45.38%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a long call on ELTX?
Long calls on ELTX express a bullish thesis with defined risk; traders use them ahead of ELTX catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
How does current ELTX implied volatility affect this long call?
ELTX ATM IV is at 158.30% with IV rank near 28.52%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.

Related ELTX analysis